Connect with us

Hi, what are you looking for?

Stock

Eli Lilly: BofA says buy the dip after shares slide on Q4 miss

Investing.com– Eli Lily’s shares fell sharply on Tuesday after the pharmaceutical company posted weaker-than-expected fourth quarter revenue, although BofA analysts said this presented a buying opportunity.

Eli Lilly and Company (NYSE:LLY) shares slid 6.6% to $744.91, after it said it expects Q4 revenue at $13.5 billion- weaker than street expectations of $14.08 billion. The miss was driven largely by softer-than-expected sales of its Mounjaro and Zepbound drugs, which was somewhat expected by investors.

BofA said the share losses offered a “particularly good buying opportunity,” stating that LLY still remained one of two major companies that should continue to dominate a large market- weight loss drugs.

LLY forecast 2025 sales between $58 billion and $61 billion- the midpoint of which is slightly above market estimates of $58.52 billion.

BofA maintained LLY at Buy and a price target of $997.0, but said it was reviewing its estimates on the stock.

BofA noted that the Q4 revenue miss was “still a miss.” The brokerage also flagged recent questions about softer than initially anticipated demand, especially given that LLY ramped up supply of its Mounjaro and Zepbound drugs in recent quarters.

While optimism over weight loss drugs sparked strong gains in LLY through early-2024, sales of the two had also missed expectations in the October quarter, keeping LLY shares rangebound ever since.

Still, LLY is seeking to expand its customer base for its flagship weight-loss drugs. The company plans to release Mounjaro in China, India, Brazil, and Mexico in 2025.

The company, along with Copenhagen-listed Novo Nordisk A/S (NYSE:NVO)- are the only two major makers of weight-loss drugs, which is a category that shot up in popularity over the past year, especially with the launch of Novo Nordisk’s Ozempic.

This post appeared first on investing.com

You May Also Like

Editor's Pick

Adani Group shares experienced a rebound on Monday, recovering from last week’s steep losses sparked by U.S. criminal charges against Chairman Gautam Adani and...

Investing

A rogue employee was responsible for hiding $151 million in delivery expenses over the course of nearly three years, Macy’s said Wednesday. In a...

Economy

By Leika Kihara TOKYO (Reuters) -Some Bank of Japan policymakers saw conditions falling into place for an imminent rate hike with one predicting a...

Editor's Pick

Kohl’s Corporation (NYSE: KSS) shares plunged 11% following a disappointing Q3 earnings report and a sharp downgrade of its fiscal 2024 outlook. The department...



Disclaimer: Techreportdiversity.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


Copyright © 2024 Techreportdiversity.com